AstraZeneca’s drug cuts risk of lung cancer death by 51%, trials show
HQ Team June 5, 2023: AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the
"This new work expands on important issues, such as the clinical evidence on endometriosis in adolescents and postmenopausal women."
HQ Team June 2, 2023: Instead of breaking internal walls in a building to connect two room spaces, scientists have developed a technique